About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Emcure Pharmaceuticals Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
544210
ISIN Demat
INE168P01015
Book Value
183.16
NSE Code
EMCURE
Dividend Yield %
0.20
Market Cap
287382.50
P/E
44.99
EPS
33.70
Face Value
10
BSE
NSE
06-Feb-2026
BSE
NSE
NSE F & O
06-Feb-2026
BSE
NSE
NSE F & O
Last Price
1515.95
Net Change
32.5
% Change
2.19%
Prev.Close
1483.45
Open
1467.35
High
1520.00
Low
1460.90
Volume
5211
Last Price
1515.70
Net Change
33.4
% Change
2.25%
Prev.Close
1482.30
Open
1475.00
High
1520.00
Low
1461.10
Volume
94187
Value
7794063
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
1520.00
52-Week High
1585.50
52-Week Low
890.00
Value
141155449.5
Best Buy
1515.70
Best Sell
0.00
Best Quantity
30
Sell Quantity
0
Today's Range
1520.00
52-Week High
1585.60
52-Week Low
889.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
30
Price
1515.70
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Dividend
30 %
14-Aug-25
Company News
22-12-2025
Emcure Pharmaceuticals la...
22-12-2025
Emcure Pharmaceuticals in...
22-12-2025
Emcure Pharmaceuticals in...
27-11-2025
Emcure Pharmaceuticals in...
22-11-2025
Emcure Pharmaceuticals in...
19-11-2025
Emcure Pharmaceuticals i...
10-11-2025
Emcure Pharma, Novo Nordi...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.